Search results
Results from the WOW.Com Content Network
Lenalidomide, sold under the brand name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (MDS). [8] For multiple myeloma, it is a first line treatment, and is given with dexamethasone . [ 8 ]
NCIRD supports and supervises state and local agencies working on immunization activities and commercial contracting for vaccine supply and distribution. NCIRD supports a national framework for surveillance of diseases for which immunizing agents are increasingly becoming available from commercial pharmaceutical companies, and assists health departments in developing vaccine information ...
States are also taking action. AARP reports that last year states passed nearly two dozen bills to make prescription drugs more affordable, with another 45 bills in 17 states in play this year ...
Full map including municipalities. State, territorial, tribal, and local governments responded to the COVID-19 pandemic in the United States with various declarations of emergency, closure of schools and public meeting places, lockdowns, and other restrictions intended to slow the progression of the virus.
Other drugs, including Revlimid, used to treat multiple myeloma, rose by 7%, to a list price of more than $89,000 per month. Black people in the U.S. are more likely to be diagnosed with the ...
KFF found that for the five drugs with the highest per capita Part D expenditures in 2021 used by more than 10,000 Part D enrollees — Revlimid, Pomalyst, Imbruvica, Jakafi and Ibrance, all ...
Starting January 2020, Messonnier helped lead the CDC efforts to address and combat the emerging threat of COVID-19, the disease caused by the novel coronavirus (SARS-CoV-2). [5] When 195 Americans were evacuated out of Wuhan because of the virus, the CDC moved to quarantine all of them, with Messonnier noting: "While we realize this is an ...
The cap doesn't apply to drugs administered by doctors. The cap is part of the Inflation Reduction Act, the 2022 federal climate and health care bill that also empowered Medicare to negotiate drug ...